In the absence of effective interventions to prevent preterm births, improved survival of
infants who are born at the biological limits of viability has relied on advances in perinatal …

Background Bronchopulmonary dysplasia (BPD) is the result of a complex process in which
several prenatal and/or postnatal factors interfere with lower respiratory tract development …

Rationale: Mesenchymal stem/stromal cell (MSC) therapies have shown promise in
preclinical models of pathologies relevant to newborn medicine, such as bronchopulmonary …

Chronic lung diseases pose a tremendous global burden. At least one in four people suffer
from severe pulmonary sequelae over the course of a lifetime. Despite substantial …

Background—Hypoxia induces an inflammatory response in the lung manifested by
alternative activation of macrophages with elevation of proinflammatory mediators that are …

The acute respiratory distress syndrome (ARDS) causes 40% mortality in approximately
200,000 critically ill patients annually in the United States. ARDS is caused by protein-rich …

Objective To assess the safety and feasibility of allogeneic human umbilical cord blood
(hUCB)-derived mesenchymal stem cell (MSC) transplantation in preterm infants. Study …

The new bronchopulmonary dysplasia : Current Opinion in Pediatrics The new
bronchopulmonary dysplasia : Current Opinion in Pediatrics Log in or Register Subscribe to …

Excessive inflammation induced by various risk factors is associated with the development
of bronchopulmonary dysplasia (BPD). Caffeine exerts potent anti-inflammatory effects as a …

Chronic obstructive pulmonary disease (COPD), a major cause of death and morbidity
worldwide, is characterized by expiratory airflow limitation that is not fully reversible …